Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease - Where Do We Stand in 2025
ERN ReCONNET via YouTube
Overview
Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Join a comprehensive webinar exploring the latest developments in treating systemic sclerosis-associated interstitial lung disease (SSc-ILD). Learn about evolving treatment landscapes, new drug developments, and current strategic approaches from renowned expert Prof. David Launay of Lille University Hospital. Gain insights into recommended guidelines, current knowledge, and upcoming challenges in managing this complication. Understand the patient's perspective on ILD while benefiting from the expertise of moderators Prof. Vanessa Smith and Prof. Marco Matucci Cerinic. Discover the latest research findings from Prof. Launay, a distinguished researcher with over 400 published manuscripts and president of the French Research Group on Systemic Sclerosis, as he shares his extensive knowledge in auto-immune diseases and translational research in inflammation. Explore current treatment options, understand unmet needs, and stay updated with the most recent therapeutic strategies in SSc-ILD management.
Syllabus
Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025?
Taught by
ERN ReCONNET